Literature DB >> 31606338

Progression and projection for hip surgery in France, 2008-2070: Epidemiologic study with trend and projection analysis.

Roger Erivan1, Guillaume Villatte2, Julien Dartus3, Nicolas Reina4, Stéphane Descamps2, Stéphane Boisgard2.   

Abstract

INTRODUCTION: Hip replacement was declared "operation of the century" in tribute to the functional improvement it provides. Frequency is increasing, but it is difficult to estimate the actual number of procedures performed and the expected progression, because of changes in indications and lengthening life-expectancy, and also, in France, because there is no registry. As data are lacking in France, we conducted an investigation 1) to update the number of hip surgeries in France, and 2) to forecast progression over the coming decades, considering extreme scenarios. HYPOTHESIS: The number of hip procedures can be expected to increase considerably over the coming 50 years. MATERIAL AND
METHOD: A study was conducted to analyze national coding data for the number of hip surgeries performed in France. Two scenarios were defined: one taking account of population progression and age structure, the other also extrapolating trends observed over recent years. Current hip surgery activity in France was measured, and progression estimated according to population changes.
RESULTS: In 2018 in France, 183,139 procedures were coded as principally concerning the hip. There was a clear predominance of reconstruction procedures, with 148,965 primary hip replacements, 124,251 of which were total. There were 19,304 hip replacement revision procedures. There were strong regional differences in revision according to the type of center performing surgery (p<0.0001). Between 2018 and 2050, primary hip replacement could be expected to increase by 41.9% or 114.3% and hip surgery overall by 42.0% or 98.3%, depending on the scenario. DISCUSSION: The present results are subject to future technological breakthroughs and medical discoveries, but forecast a major increase in hip surgery requirements. These results extend the present state of medical knowledge. LEVEL OF EVIDENCE: IV, descriptive epidemiological study.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Keywords:  Epidemiology; Hip; Hip replacement; National data; Prediction; Progression

Year:  2019        PMID: 31606338     DOI: 10.1016/j.otsr.2019.07.021

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  6 in total

1.  Outcomes of revision total hip arthroplasty using a vascularised anterior femoral window.

Authors:  Rajpreet Sahemey; Kanai Garala; Gurdip Chahal; Trevor Lawrence
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-09-05

2.  Early Clinical Outcomes of Short versus Long Proximal Femoral Nail Anti-rotation (PFNA) in the Treatment of Intertrochanteric Fractures.

Authors:  Jlm Loh; Dme Huang; J Lei; W Yeo; M K Wong
Journal:  Malays Orthop J       Date:  2021-07

Review 3.  Antibiotic Therapy for Prosthetic Joint Infections: An Overview.

Authors:  Benjamin Le Vavasseur; Valérie Zeller
Journal:  Antibiotics (Basel)       Date:  2022-04-05

4.  Contemporary indications for first-time revision surgery after primary cementless total hip arthroplasty with emphasis on early failures.

Authors:  Goro Motomura; Satoshi Hamai; Satoshi Ikemura; Masanori Fujii; Shinya Kawahara; Soichiro Yoshino; Yasuharu Nakashima
Journal:  J Orthop Surg Res       Date:  2021-02-17       Impact factor: 2.359

5.  Tapered wedge stems decrease early postoperative subsidence following cementless total hip arthroplasty in Dorr type C femurs compared to fit-and-fill stems.

Authors:  Satoshi Ikemura; Goro Motomura; Satoshi Hamai; Masanori Fujii; Shinya Kawahara; Taishi Sato; Daisuke Hara; Kyohei Shiomoto; Yasuharu Nakashima
Journal:  J Orthop Surg Res       Date:  2022-04-10       Impact factor: 2.359

6.  Effectiveness of self-efficacy-enhancing interventions on rehabilitation following total hip replacement: a randomized controlled trial with six-month follow-up.

Authors:  Ya Meng; Bo Deng; Xiaoyu Liang; Jiangzhen Li; Liuyi Li; Jinxia Ou; Shuping Yu; Xingxian Tan; Yumei Chen; Meifen Zhang
Journal:  J Orthop Surg Res       Date:  2022-04-10       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.